HomeRNAZ • NASDAQ
add
Transcode Therapeutics Inc
Previous close
$0.60
Day range
$0.60 - $0.64
Year range
$0.22 - $20.69
Market cap
10.56M USD
Avg Volume
2.51M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.11M | -0.18% |
Net income | -5.19M | -19.56% |
Net profit margin | — | — |
Earnings per share | -29.60 | 77.51% |
EBITDA | -5.08M | 0.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.35M | -6.10% |
Total assets | 4.82M | -17.97% |
Total liabilities | 3.50M | -7.57% |
Total equity | 1.32M | — |
Shares outstanding | 17.27M | — |
Price to book | 3.33 | — |
Return on assets | -211.06% | — |
Return on capital | -395.01% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -5.19M | -19.56% |
Cash from operations | -2.34M | 46.72% |
Cash from investing | -4.56K | 74.84% |
Cash from financing | 785.20K | -87.65% |
Net change in cash | -1.56M | -179.96% |
Free cash flow | -240.34K | 92.13% |
About
Founded
2016
Headquarters
Website
Employees
10